SCR-LIP-000248 · Claim · machine-readable JSON →

In a 10-year retrospective study of 106 lipedema patients undergoing multistage lymphatic-sparing liposuction (PAL/WAL), median CDT composite scores dropped 37.5% and pain VAS fell from 80 to 30 (p<0.0001), with 34.9% no longer needing compression garments, low complication rates (1.3% wound infection, 0.7% seroma), and better outcomes in younger patients with BMI ≤35 and earlier disease stage.

Emerging clinical association Evidence certainty: low (GRADE)

Created: 2026-05-31 · Last updated: 2026-05-31

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

DOI:10.1097/prs.0000000000008880 — supporting · case series · 2022
Retrospective, single-center, noncomparative study reporting significant patient-reported symptom improvement and low complication rates after liposuction, directly addressing efficacy and safety; uncontrolled design and reliance on subject
DOI:10.3390/jcm14010279 — supporting · case series · 2022
Retrospective before-and-after study (level IV evidence) directly evaluating liposuction outcomes in lipedema, reporting symptom improvement and reduced need for conservative therapy; supports effectiveness with patient-selection caveats.

Conditionlipedema

Scopeauto-ingested from Layer 1 surveillance

Auto-ingested single source; not yet human-reviewed.